M42 launched Med42, a new open-access Clinical Large Language Model (LLM), powered with 70 billion parameters, generative artificial intelligence (AI) to enhance clinical decision-making and access to medical knowledge.
Hasan Jasem Al Nowais, managing director and group chief executive officer of M42, said, “Med42 will accelerate global access to healthcare knowledge and embodies our commitment to making a transformative impact across the healthcare sector. M42 is pushing the boundaries of healthcare innovation and charting a path towards more personalised, patient-centric care.”
AI assistant
Acting as an AI assistant for healthcare professionals, it can also develop personalised treatment plans by analysing a patient’s medical records. It can also help medical professionals access information faster, decide on proper medical dosages, and work on treatment plans.
“Our partnerships with technology leaders, including Cerebras, enable us to bring this vision to life and achieve our long-term transformative objectives,” Ashish Koshy, group chief operating officer of M42, said.
Andrew Feldman, co-founder and chief executive officer of Cerebras Systems, said, “Our strategic partnership with G42 and its portfolio companies is designed to change the AI landscape. Our collaboration has already delivered Condor Galaxy 1, the largest AI supercomputer in the world, as well as Jais, the leading Arabic LLM, to the community. Today, we helped bring another state-of-the-art LLM to the world, Med42, with huge benefits for the healthcare landscape.”
